Nykode Therapeutics AS

OB:NYKD Stock Report

Market Cap: NOK 819.6m

Nykode Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OB:NYKD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Dec 24BuyNOK 300,000Caaby ASCompany100,000NOK 3.00
20 Dec 24SellNOK 300,000Christian ÅbyholmIndividual100,000NOK 3.00
08 Nov 24BuyNOK 9,585,978Norda ASACompany5,000,000NOK 1.92
08 Nov 24BuyNOK 9,585,978Norda ASACompany5,000,000NOK 1.92
21 Aug 24BuyNOK 282,500Alf Gunnar NicklassonIndividual50,000NOK 5.65
26 Mar 24BuyNOK 374,248Bernd SeizingerIndividual25,000NOK 14.97
21 Mar 24BuyNOK 310,271Birgitte VolckIndividual20,311NOK 15.28
13 Mar 24BuyNOK 139,969Harald GurvinIndividual10,000NOK 14.00
08 Mar 24BuyNOK 370,250Bernd SeizingerIndividual25,000NOK 14.81
08 Mar 24BuyNOK 552,400Alf Gunnar NicklassonIndividual40,000NOK 13.81
04 Mar 24BuyNOK 331,832Harald GurvinIndividual20,000NOK 16.59
29 Feb 24BuyNOK 100,260Michael EngsigIndividual6,000NOK 16.71

Insider Trading Volume

Insider Buying: NYKD insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of NYKD?
Owner TypeNumber of SharesOwnership Percentage
Public Companies12,996,7553.98%
VC/PE Firms17,815,3115.46%
Individual Insiders52,115,21116%
Private Companies70,241,97621.5%
General Public80,989,98224.8%
Institutions92,387,20928.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 70.22% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.6%
Jan Haudemann-Andersen
41,189,050NOK 103.4m0%no data
9.24%
Rasmussengruppen AS
30,180,750NOK 75.8m0%10.26%
5.46%
RADFORSK
17,815,311NOK 44.7m0%50.0%
5.42%
Victoria India Fund AS
17,705,175NOK 44.4m0%no data
4.84%
State Street Global Advisors, Inc.
15,818,858NOK 39.7m0%no data
4.61%
Capital Research and Management Company
15,050,000NOK 37.8m0%no data
3.98%
Norda ASA
12,996,755NOK 32.6m62.5%no data
3.23%
Joh Johannson Eiendom AS
10,561,631NOK 26.5m0%no data
2.29%
Vatne Capital AS
7,485,857NOK 18.8m0%no data
2%
Om Holding AS
6,519,525NOK 16.4m0%no data
1.94%
Handelsbanken Asset Management
6,331,396NOK 15.9m0%no data
1.52%
Simen Thorsen
4,950,000NOK 12.4m0%no data
1.38%
Portia AS
4,500,000NOK 11.3m0%no data
1.37%
Krag Invest As
4,470,100NOK 11.2m0%no data
1.19%
Alden AS
3,900,000NOK 9.8m0%no data
1.06%
JPMorgan Chase & Co, Brokerage and Securities Investments
3,471,645NOK 8.7m0%no data
1.03%
AS Kassiopeia
3,365,000NOK 8.4m0%no data
0.97%
Swedbank Asset Management AS SMB
3,155,150NOK 7.9m0%0.91%
0.94%
KLP Kapitalforvaltning AS
3,081,540NOK 7.7m-0.63%no data
0.94%
Danske Invest Asset Management AS
3,078,203NOK 7.7m0%0.23%
0.93%
Danske Capital AB
3,043,200NOK 7.6m0%0.06%
0.92%
Borgano AS
3,000,000NOK 7.5m0%no data
0.87%
Tore Voldberg
2,850,000NOK 7.2m0%no data
0.73%
Lani Invest As
2,399,916NOK 6.0m0%no data
0.73%
Northern Trust Global Investments
2,368,365NOK 5.9m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/21 19:55
End of Day Share Price 2025/02/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nykode Therapeutics AS is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Viktor SundbergABG Sundal Collier Sponsored
Geir HolomDNB Markets
Patrick TrucchioH.C. Wainwright & Co.